A vial and syringe are seen in front of a displayed Pfizer logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
Pfizer is in discussions with the Indian government seeking an “expedited approval pathway” for its COVID-19 vaccine, its CEO Albert Bourla said on LinkedIn on Monday, announcing a donation of medicines worth more than $70 million.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” he said.
“We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
Our Standards: The Thomson Reuters Trust Principles.
Global Fashion Agenda has revealed Building Resilient Futures as the theme for the Global Fashion…
The Electricity Connect 2025 conference in Jakarta spotlighted Indonesia’s energy transition, with Huawei recognised as…
After years of material science breakthroughs, a team proved that a rugged, sea-ready composite could…
TAHO, a Venice-based compute startup founded by ex-Meta and Google engineers, raised $3.5 million in…
The 9th Future Investment Initiative in Riyadh spotlighted how AI is rapidly redefining global growth,…
Onward Robotics has appointed Brendon Bielat as Chief Product Officer, strengthening its leadership team as…